Al Razi Medical Co. (9572)
Tadawul
24.15
-1.05 (-4.17%)
Real-time Data
07:00 AM
Day's Range
24.0125.12
52 wk Range
22.4939.90
Financial Statements - 9572 - Al Razi Medical Co.
Revenue
74.38M▲ 21.2%
Net Income
819.46K▲ 366.0%Net Margin 1.1%
EBITDA
5.40M▲ 23.2%
Free Cash Flow
3.84M▲ 252.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 74.38M | 61.35M | 61.33M | 52.39M |
| Cost of Goods | 55.08M | 44.76M | 43.74M | 36.29M |
| Gross Profit | 19.29M | 16.58M | 17.58M | 16.09M |
 Operating Expense | - | - | - | - |
| Operating Income | 1.96M | 820.36K | 1.72M | 2.90M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 1.06M | 529.66K | 1.08M | 2.42M |
| Income Tax | 249.05K | 353.79K | 399.73K | 410.71K |
| Net Income | 819.46K | 175.86K | 685.96K | 2.01M |
| EPS Basic | 0.54 | 0.12 | 0.45 | 1.32522 |
| EPS Diluted | 0.54 | 0.12 | 0.45 | 1.32522 |
| Basic Shares Outstanding | 1.52M | 1.52M | 1.52M | 1.52M |
| Diluted Shares Outstanding | 1.52M | 1.52M | 1.52M | 1.52M |
| Ebit | 1.89M | 1.04M | 1.56M | 2.72M |
| Ebitda | 5.40M | 4.38M | 5.24M | 5.27M |
| Net Income Continuous Operations | 1.06M | 529.66K | 1.08M | - |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
